The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Clinical trial NCT00857259 · TERMINATED

Trial details

NCT number: NCT00857259
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Choroidal Neo-Vascular Age-onset Macular Degeneration Age-related Macular Degeneration

Start date: 2009-02-01
Primary completion: 2010-07-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.